Page 91 - CIBERER2016-ENG

Most relevant scientific articles
• Ortiz J.U., Eixarch E., Peguero A., Lobmaier S.M., Bennasar M., Martinez J.M. et al. Chorioamniotic membrane separation after fetoscopy in monochorionic twin pregnancy: Incidence and impact on perinatal outcome. Ultrasound in Obstetrics and Gynecology. 2016.
• Masoller N., Sanz-Cortes M., Crispi F., Gomez O., Bennasar M., Egana-Ugrinovic G. et al. Severity of Fetal Brain Abnormalities in Congenital Heart Disease in Relation to the Main Expected Pattern of in utero Brain Blood Supply. Fetal Diagnosis and Therapy. 2016;39(4):269-278.
• Eixarch E., Munoz-Moreno E., Bargallo N., Batalle D., Gratacos E. Motor and cortico-striatal-thalamic connectivity alterations in intrauterine growth restriction Presented in part at the 22nd World Congress on Ultrasound in Obstetrics and Gynaecology, Copenhagen, Denmark, September 9-12, 2012.American Journal of Obstetrics and Gynecology. 2016;214(6): 725.e1-725.e9.
• Garcia-Otero L., Lopez M., Gomez O., Gonce A., Bennasar M., Martinez J.M. et al. Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling. AIDS. 2016.
• Padilla N, Fransson P, Donaire A, Figueras F, Arranz A, Sanz-Cortés M et al. Intrinsic Functional Connectivity in Preterm Infants with Fetal Growth Restriction Evaluated at 12 Months Corrected Age. Cerebral cortex (New York, N.Y.: 1991). 2016.
Hightlights
During 2016 the Fetal and Perinatal Medicine research group led by Dr. Gratacós, has contributed with several clinical algorithms for the screening and the early detection of materno-fetal pathologies, has validated a series of placental insufficiency biomarkers, has helped better define biomarkers in brain images obtained by ultrasound and magnetic resonance, has demonstrated the postnatal persistence of prenatally induced cardiac remodeling and has provided evidence in the mitochondrial toxicity associated to toxic (in collaboration con Cardellach López, Francesc - CB06/07/1002) exposure during the prenatal life. We have also launched a very ambitious project in fetal surgery (FIRST Project, in collaboration with ICFO, IQS, IBEC, UPF) that aims to develop several techniques to aid intrauterine surgery of rare diseases such as congenital diaphragmatic hernia, spina-bifida and fetal transfusion. In addition, the team has stated several clinical trials aimed to improve materno-fetal health, such as a genetic therapy trial to improve placental angiogenesis (Proyecto Europeo FP7 EVERREST), nutritional strategies and stress reduction to improve fetal growth (IMPACT), and a project to define the optimal timing of completion in fetuses with cerebral redistribution signs (RATIO37). Socially, our research group collaborates with various patients and families with rare diseases associations, such as the group called “La vida con hernia diafragmática congénita”.
ER
research groups 91